Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor immunity against adult T-cell leukemia.
Kannagi M, Harashima N, Kurihara K, Ohashi T, Utsunomiya A, Tanosaki R, Masuda M, Tomonaga M, Okamura J. Kannagi M, et al. Among authors: utsunomiya a. Cancer Sci. 2005 May;96(5):249-55. doi: 10.1111/j.1349-7006.2005.00050.x. Cancer Sci. 2005. PMID: 15904464 Free article. Review.
Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.
Ishitsuka K, Ikeda R, Utsunomiya A, Uozumi K, Hanada S, Suzuki S, Takeuchi S, Takatsuka Y, Takeshita T, Ohno N, Arima T. Ishitsuka K, et al. Among authors: utsunomiya a. Leuk Lymphoma. 2002 May;43(5):1107-14. doi: 10.1080/10428190290021461. Leuk Lymphoma. 2002. PMID: 12148893
Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.
Takenaka T, Itoh K, Suzuki T, Utsunomiya A, Matsuda S, Chou T, Sai T, Sano M, Konda S, Ohno T, Mikuni C, Deura K, Yamada T, Mizorogi F, Nagoshi H, Tomonaga M, Hotta T, Kawano K, Tsushita K, Hirano M, Shimoyama M; Lymphoma Study Group of the Japan Clinical Oncology Group. Takenaka T, et al. Among authors: utsunomiya a. Int J Hematol. 2004 Feb;79(2):165-73. doi: 10.1532/ijh97.03115. Int J Hematol. 2004. PMID: 15005346 Clinical Trial.
Adult T-cell leukemia: future prophylaxis and immunotherapy.
Kannagi M, Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Masuda M. Kannagi M, et al. Among authors: utsunomiya a. Expert Rev Anticancer Ther. 2004 Jun;4(3):369-76. doi: 10.1586/14737140.4.3.369. Expert Rev Anticancer Ther. 2004. PMID: 15161436 Review.
Potential immunogenicity of adult T cell leukemia cells in vivo.
Kurihara K, Harashima N, Hanabuchi S, Masuda M, Utsunomiya A, Tanosaki R, Tomonaga M, Ohashi T, Hasegawa A, Masuda T, Okamura J, Tanaka Y, Kannagi M. Kurihara K, et al. Among authors: utsunomiya a. Int J Cancer. 2005 Mar 20;114(2):257-67. doi: 10.1002/ijc.20737. Int J Cancer. 2005. PMID: 15551352 Free article.
Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma.
Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M, Tomonaga M, Harada M, Kimura N, Masuda M, Kawano F, Yufu Y, Hattori H, Kikuchi H, Saburi Y. Okamura J, et al. Among authors: utsunomiya a. Blood. 2005 May 15;105(10):4143-5. doi: 10.1182/blood-2004-11-4193. Epub 2005 Jan 21. Blood. 2005. PMID: 15665110 Free article.
Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.
Inagaki A, Ishida T, Ishii T, Komatsu H, Iida S, Ding J, Yonekura K, Takeuchi S, Takatsuka Y, Utsunomiya A, Ueda R. Inagaki A, et al. Among authors: utsunomiya a. Int J Cancer. 2006 Jun 15;118(12):3054-61. doi: 10.1002/ijc.21688. Int J Cancer. 2006. PMID: 16425276 Free article.
389 results